cagrilintide clinical trials A new drug combo of semaglutide (GLP-1 receptor agonist) with (amylin analogue) failed to do as well as tirzepatide (GLP-1/GIP receptor agonist). The future of these medicines is hitting different receptors Trial Scorecard: REDEFINE 1 and

Explore more peptide treaments Advancing peptide research through quality, innovation, and scientific excellence

D-retro-inverso refers to a peptide made with D-amino acids in reverse sequence order

mRNA expression of neurotrophins and members of the trk family in the rat brain after treatment with L-deprenyl

Within-participant estimates were even higher, with a 0.25 point drop in scores expected for each additional percent of sleep efficiency relative to the individual mean

Is AOD9604 a drug or supplement

Human oral isolate Lactobacillus fermentum AGR1487 reduces intestinal barrier integrity by increasing the turnover of microtubules in Caco-2 cells